Document is current
Any future updates will be listed below
-
Authors
Fanelli, Elvira
Picca, Giulia
Airale, Lorenzo
Astarita, Anna
Mingrone, Giulia
Catarinella, Cinzia
Votta, Simona
Colomba, Anna
Cesareo, Marco
Leone, Dario
Paladino, Arianna
Rabbia, Franco
Bringhen, Sara
Gay, Francesca
Veglio, Franco
Milan, Alberto
Vallelonga, Fabrizio
- License Information
-
More Information
Article History
Received: 14 September 2024
Revised: 14 December 2024
Accepted: 21 December 2024
First Online: 22 January 2025
Compliance with ethical standards
:
: Alberto Milan received honoraria for advisory board from Amgen. Sara Bringhen received honoraria from Bristol-Myers Squibb, Celgene, Amgen, and Janssen; advisory boards for Amgen, Karyopharm, Janssen, and Celgene; consultancy fees from Takeda and Janssen. Francesca Gay received honoraria from Amgen, Janseen, Celgene, BMS, Takeda, and Abbvie; advisory boards for Amgen, Janseen, Celgene, BMS, Takeda, and Abbvie; advisory adaptive for Roche Oncopeptides. The other authors declare no conflict of interest. The other authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, and/or interpretation of data; in the writing of the manuscript and/or in the decision to publish the results.
